Nom du produit:ethyl 2-((2-aminothiazol-5-yl)thio)acetate
IUPAC Name:ethyl 2-[(2-amino-1,3-thiazol-5-yl)sulfanyl]acetate
- CAS：859522-19-3
- Formule moléculaire：C7H10N2O2S2
- Pureté：95%
- Numéro de catalogue：CM132250
- Poids moléculaire：218.29
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:859522-19-3
- Formule moléculaire:C7H10N2O2S2
- Point de fusion:-
- Code SMILES:O=C(OCC)CSC1=CN=C(N)S1
- Densité:
- Numéro de catalogue:CM132250
- Poids moléculaire:218.29
- Point d'ébullition:368.9°C at 760 mmHg
- N° Mdl:
- Stockage:Keep in dark place, store at 2-8°C.
Category Infos
- Thiazoles
- Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.
Column Infos
- Cadisegliatin
- vTv Therapeutics announces FDA submission for first phase 3 study of Cadisegliatin in patients with type 1 diabetes. Cadisegliatin (TTP399) is developed as an adjunctive therapy to insulin for the treatment of type 1 diabetes, and the phase 3 trial evaluates its safety and efficacy.
Glucokinase (GK) is mainly concentrated in liver cells, and involved in the regulation of glucose metabolism. Cadisegliatin (TTP399) is a liver-selective glucosekinase activator with a mechanism of action different from that of antidiabetic drugs. It binds to the allosteric site of GK and restores innate glucose-regulating capacity of the liver, not disrupting the interaction between GK and GKRP. Cadisegliatin previously received a Breakthrough Therapy designation from the U.S. FDA.
Recherche 
+86 21 5895 0110 
